UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway Journal article
Jiang, Xue, Yi, Saini, Liu, Qin, Su, Dapeng, Li, Liangyuan, Xiao, Chenghong, Zhang, Jinqiang. Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway[J]. Journal of Neuroinflammation, 2022, 19, 115.
Authors:  Jiang, Xue;  Yi, Saini;  Liu, Qin;  Su, Dapeng;  Li, Liangyuan; et al.
Favorite | TC[WOS]:44 TC[Scopus]:45  IF:9.3/9.8 | Submit date:2022/08/02
Asperosaponin Vi  Depression  Microglia  Hippocampus  Ppar-γ  Neuroinflammatory  
Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A Journal article
Liu J., Wang D., Li S.-Q., Yu Y., Ye R.D.. Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A[J]. Journal of Neuroinflammation, 2016, 13(1).
Authors:  Liu J.;  Wang D.;  Li S.-Q.;  Yu Y.;  Ye R.D.
Favorite | TC[WOS]:38 TC[Scopus]:42 | Submit date:2018/11/07
Alzheimer's Disease  Microglial Activation  Serum Amyloid a  Tau Phosphorylation  
Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease Journal article
Li S.-Q., Yu Y., Han J.-Z., Wang D., Liu J., Qian F., Fan G.-H., Bucala R., Ye R.D.. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease[J]. Journal of Neuroinflammation, 2015, 12(1).
Authors:  Li S.-Q.;  Yu Y.;  Han J.-Z.;  Wang D.;  Liu J.; et al.
Favorite | TC[WOS]:43 TC[Scopus]:43 | Submit date:2018/11/07
Alzheimer's Disease  Astrocyte Activation  Macrophage Migration Inhibitory Factor  Tau Phosphorylation